A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution?

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue SUPPL., 1998, Pages

  Lurie, Peter ^a,d   Stephen Jones, T ^b   Foley, Jill ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

AIDS; Injection drug users; Injection frequency; Needle exchange; Pharmacies

Indexed keywords

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SYRINGE; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 13144252209     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199802001-00009     Document Type: Article

References (60)

1. Normand J, Vlahov D, Moses L. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press, 1995.
2. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996;86:642-54.
3. Gostin LO, Lazzarini Z, Jones TS, Flaherty KM. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: a national survey on the regulation of syringes and needles. JAMA 1997;277:53-62.
4. Nelson KE, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony JC. Human immunodeficiency virus infection in diabetic intravenous drug users. JAMA 1991;266:2259-61.
5. Groseclose SL, Weinstein B, Jones TS, Valleroy L, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices on injecting-drug users and police officers - Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:82-9.
6. Espinoza P, Bouchard I, Ballian P. Has the open sale of syringes modified the syringe exchanging habits of drug addicts [abstract 8522]? Final program and abstracts of the IV International Conference on AIDS, Stockholm, 1988.
7. Ingold FR, Ingold S. The effects of the liberalization of syringe sales on the behaviour of intravenous drug users in France. Bull Narc 1989;41:67-81.
8. Tempesta E, Di Giannantonio M. The Italian epidemic: a case study. In Strang J, Stimson GV (eds). AIDS and drug misuse: the challenge for policy and practice in the 1990s. London: Routledge, 1990:108-17.
9. Vlahov D, Astemborski J, Solomon L, Nelson KE. Field effectiveness of needle disinfection among injecting drug users. J Acquir Immune Defic Syndr 1994;7:760-6.
10. Titus S, Marmor M, Des Jarlais D, Kim M, Wolfe H, Beatrice S. Bleach use and HlV seroconversion among New York City injection drug users. J Acquir Immune Defic Syndr 1994;7:700-4.
11. Moss AR, Vranizan K, Gorter R, Bacchetti P, Watters J, Osmond D. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990, AIDS 1994;8:223-31.
12. Flynn N, Jain S, Keddie EM, et al. In vitro activity of readily available household materials against HIV-1: is bleach enough? J Acquir Immune Defic Syndr 1994;7:747-53.
13. Shapshak P, McCoy CB, Shah SM, et al. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. J Acquir Immune Defic Syndr 1994;7:754-9.
14. Gleghorn AA, Doherty MC, Vlahov D, Celentano DD, Jones TS. Inadequate bleach contact times during syringe cleaning among injection drug users. J Acquir Immune Defic Syndr 1994;7:767-72.
15. U.S. Public Health Service. HIV prevention bulletin: medical advice for persons who inject illicit drugs. Atlanta, GA and Rockville, MD: U.S. Public Health Service, May 8, 1997.
16. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:202-7.
17. Newmeyer JA. The prevalence of drug use in San Francisco in 1987. J Psychoactive Drugs 1988;20:185-9.
18. Butynski W, Reda JL, Canova D, et al. State resources and services related to alcohol and other drug abuse problems: fiscal year 1990. Washington, DC: National Association of State Alcohol and Drug Abuse Directors, Inc., 1991.
19. Dondero T. Human immunodeficiency virus infection in the United States: a review of current knowledge. MMWR 1987;36: S-6.
20. Centers for Disease Control and Prevention. Update: syringe exchange programs - United States, 1996. MMWK 1997;46:565-8.
21. Jones TS, Lurie P. Can enough syringes be provided to allow drug injectors to use a new syringe for every injection [abstract no. We.C.3555]? International Conference on AIDS, July 7-12, 1996; 11(2):154.
22. Jones TS, Lurie P. Can enough syringes be provided to allow drug injectors to use a new syringe for every injection [abstract no. We.C.3555]? International Conference on AIDS, July 7-12, 1996; 11(2):154.
23. Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl 1):S133-8.
24. Lurie P, Reingold AL, Bowser B, et al. The public health impact of needle exchange programs in the United States and abroad, vol. 1. San Francisco: University of California, October 1993.
25. Lurie P, Gorsky R, Jones TS, Shomphe L. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl 1):S126-32.
26. Lart R, Stimson G. National survey of syringe exchange schemes in England. Br J Addiction. 1990;85:1433-43.
27. Keys Young MSJ. Fitpacks evaluation study. Sydney: AIDS Bureau, New South Wales Health Department, March 1992.
28. Intergovernmental Committee on AIDS. A report on HIV/AIDS activities in Australia 1990-1991. Canberra: Australian Government Publishing Service, 1991.
29. Lungley S, Baker M. The needle and syringe exchange scheme in operation. Wellington: New Zealand Department of Health, 1990.
30. Friedrichs C, Michels I. The availability of sterile syringes in the Federal Republic of Germany and the offer by AIDS-service organizations and drug counselling centres for an exchange of syringes [abstract 3069]. Final program and abstracts of the VI International Conference on AIDS, San Francisco, 1990.
31. Lurie P, Reingold AL, Bowser B, et al. The public health impact of needle exchange programs in the United Stares and abroad, vol. 2. San Francisco: University of California, October 1993.
32. Roggli C. Flash HIV prevention amongst socially integrated intravenous drug users [abstract PO-C24-3195]. Final program and abstracts of the IX International Conference on AIDS, Berlin, 1993.
33. Zubia L, Menoyo C, Elizalde B, Urzelai A, Saenz de Buruage J, Zulaica D. The anti-AIDS kit: two years experience [abstract PoD 5096]. Final program and abstracts of the VIII International Conference on AIDS, Amsterdam, 1992.
34. Zulaica D, Zubia I, Elizalde B, Garcia I. A new AIDS programme for heroin addicts based on the cooperation of chemists shops (the anti-AIDS kit) [abstract SC 738]. Final program and abstracts of the VI International Conference on AIDS, San Francisco, 1990.
35. Doorninck, M van, de Loor, A. The Basics Box: a box for safer injecting and the prevention of needle stick injuries [abstract 559C]. Final program and abstracts of the X International Conference on AIDS, Yokohama, 1994.
36. Agnoletto V, Tradati C, Ceserani N, et al. Street work and syringe exchange machines as complementary strategies of HIV harm reduction among active drug users: an Italian model [abstract WS-D09-4). Final program and abstracts of the IX International Conference on AIDS, Berlin, 1993.
37. Stover H. Needle exchange VI: slot machines and exchange programmes, an important HIV-preventive measure. Newsletter of the International Working Group on AIDS and Drug Use 1989;4:12-A.
38. Stark K, Leicht A, Mueller R, Bienzle U. Behavioral characteristics and HIV infection in users of syringe vending machines [abstract PoC 4264]. Final program and abstracts of the VIII International AIDS Conference, Amsterdam, 1992.
39. Leicht A. Characteristics and HIV-infection of users of syringe vending-machines and exchange programs in Berlin/Germany [abstract PO-D17-3931]. Final program and abstracts of the IX International Conference on AIDS, Berlin, 1993.
40. Stimson G, Dolan K, Donoghoe M, Lart R. The future of UK syringe exchange. Int J Drug Policy 1990;2:14-7.
41. Rezza G, Buning E, Medina RDA, et al. HIV prevention strategies in injection drug users. Lausanne: Institut Universitaire De Médecine Sociale Et Préventive, 1992.
42. Wiley J, Samuel M. Prevalence of HIV infection in the USA. AIDS 1989;3(Suppl 1):71-8.
43. Millson P, Myers T, Rankin J, et al. Trends in HIV seroprevalence and risk behaviour in IDUs in Toronto. Canada [abstract PO-C15-2936]. Final program and abstracts of the IX International Conference on AIDS, Berlin, 1993.
44. Anon. AIDS and drug misuse, part 1. London: Her Majesty's Stationery Office, 1988.
45. Zellmer WA. Pharmacist involvement in needle exchange programs. American Pharmacy 1994;NS34:48-51.
46. Compton W, Cottier L, Decker S, Mager D, Stringfellow R. Legal needle buying in St. Louis. Am J Public Health 1992;82:595-6.
47. Bridges FS, Ramsey JP, Santana JC. Sale of nonprescription syringes to men and women - Florida, 1994-1995. Florida Public Health J (in press).
48. Wright-De Aguero L, Weinstein B, Jones TS, Miles J. The impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl 1):S102-10.
49. Gleghorn AA, Gee G. Vlahov D. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl 1):S89-93.
50. Lawrence D, Lawrence M, Atkinson W, Risi G, Lauro A. Needle-sharing among intravenous drug users in New Orleans. J La State Med Soc 1991;143:18-21.
51. Myers T, Cockerill R, Millson M, Rankin J, Worthington C. Canadian pharmacies response to HIV and harm reduction strategies: a report from the national survey on community pharmacies and HIV/AIDS prevention. In Proceedings: workshop on needle exchange and bleach distribution programs. Washington, DC: National Academy Press, 1994:135-51.
52. Glanz A, Byrne C, Jackson P. Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. BMJ 1989;299:1076-9.
53. Jones EM. A study of pharmacists' attitudes to a needle and syringe availability scheme in Barnet. Barnet: Barnet Health Authority, 1989.
54. Millar T. Pharmacies and syringe exchange in Liverpool. Mersey: The Drugs and HIV Monitoring Unit, Mersey Regional Health Authority, 1989.
55. De Muynck G, Todts S. Pharmacists and IVDU: possibilities for prevention [abstract SC 734]. Final program and abstracts of the VI International Conference on AIDS, San Francisco, 1990.
56. Mullins RM. Needles and syringes for IVDUs. Med J Aust 1990; 152:672.
57. Stimson GV, Keene J, Parry-Langdon N, Jones S. Evaluation of the syringe exchange programme in Wales, 1990-91: final report to Welsh office. Centre for Research on Drugs and Health Behaviour, 1991.
58. Gostin LO. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl 1):S60-70.
59. Toews DW. A communitywide needle/syringe disposal program. Am J Public Health 1995; 85:1447-8.
60. Satterfield D, Kling J. Diabetes educators encourage safe needle practice. Diabetes Educator 1991;17:321-5.